Aurora Cannabis Announces Results of 2023 Annual General Meeting


 Aurora Cannabis Inc. (the "Company" or "Aurora" ) (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, is pleased to announce the voting results from its Annual General Meeting of Shareholders (the " Meeting ") held today, Monday, August 14, 2023 by virtual webcast. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 92,897,315, representing 26.23% of Aurora's issued and outstanding common shares as of the record date.

Aurora Cannabis Inc. Logo (CNW Group/Aurora Cannabis Inc.)

All of the matters put forward before shareholders for consideration and approval, as set out in the Company's Management Information Circular dated June 30, 2023 , were approved by the requisite majority of votes cast at the Meeting. The details of the voting results for the election of directors are set out below:


Votes For

Votes Withheld

Ron Funk

21,456,189 (78.91 %)

5,734,650 (21.09 %)

Miguel Martin

23,182,258 (85.26 %)

4,009,014 (14.74 %)

Michael Singer

23,195,268 (85.30 %)

3,996,005 (14.70 %)

Norma Beauchamp

23,040,789 (84.74 %)

4,150,484 (15.26 %)

Theresa Firestone

20,769,802 (76.38 %)

6,421,470 (23.62 %)

Adam Szweras

23,765,335 (87.40 %)

3,425,938 (12.60 %)

Chitwant Kohli

20,600,774 (75.76 %)

6,590,064 (24.24 %)

Shareholders also approved the following matters:

  • setting the size of the Board at seven (7) directors;
  • a non-binding advisory resolution on the Company's approach to executive compensation; and
  • the appointment of KPMG LLP as auditors of the Company for the ensuing year.

The Company has filed a report of voting results on all resolutions voted on at the Meeting under its profile on .

About Aurora

Aurora is opening the world to cannabis, serving both the medical and consumer markets. Headquartered in Edmonton, Alberta , Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, performance, wellness and adult recreational markets wherever they are launched. Learn more at and follow us on Twitter and LinkedIn. Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".

Forward Looking Statements

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur.

These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the risk of successful integration of acquired business and operations, management's estimation that SG&A will grow only in proportion of revenue growth, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises, including the current outbreak of COVID-19, and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information form dated June 14, 2023 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR at and filed with and available on the SEC's website at . The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.

Cision View original content to download multimedia:

SOURCE Aurora Cannabis Inc.

Cision View original content to download multimedia:

News Provided by Canada Newswire via QuoteMedia

The Conversation (0)

Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call


  • Re-affirms expectation of positive annual Adjusted EBITDA 1 for fiscal 2024 and Positive Free Cash Flow 1 generation in calendar 2024
  • Announces Intention to Consolidate Common Shares
  • Q3 2024 Investor Conference call scheduled for February 8, 2024 at 8:00 a.m. Eastern Time

 Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, provided key business updates today and confirmed that it will release financial results and host an investor conference call for its third quarter of fiscal 2024 ended December 31, 2023 on February 8, 2024 .

News Provided by PR Newswire via QuoteMedia

Keep reading...Show less

Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product Launch


Available at launch exclusively to Aurora's veteran patients, new products span THC, CBD and CBG offerings to meet the discerning taste, experience and product variety patients seek

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Aurora Cannabis Announces Fiscal 2024 Second Quarter Results and Delivers Record Positive Adjusted EBITDA


  • Delivers Record Positive Adjusted EBITDA 1 of $ 3.4 Million
  • Quarterly Net Revenue 1 rose 30% YoY to $63.4 Million ; Strong Growth of 42 % in Global Medical Cannabis
  • Net cash position of over $200 Million , Expects to Repay the Remaining US$5.3 Million Balance of Convertible Senior Notes in February 2024
  • Re-Affirms Target of Achieving Positive Free Cash Flow 1 in Calendar Year 2024

Aurora Cannabis Inc. (the "Company" or "Aurora" ) (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, today announced its financial and operational results for the second quarter of fiscal year 2024. As the fiscal year 2023 consisted of three quarters, the year-over-year comparison quarter for Q2 2024 ending September 30, 2023 is Q1 2023 ending September 30, 2022 .

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Aurora Cannabis to Host Second Quarter Fiscal Year 2024 Investor Conference Call


Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian company opening the world to cannabis, announced today that it has scheduled a conference call to discuss the results for its second quarter fiscal year 2024 on Thursday, November 9, 2023 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time . The Company will report its financial results for the second quarter fiscal year 2024 after the close of markets that same day.

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Aurora Cannabis Announces Settlement of Patent Litigation


Company affirms commitment to enforce and defend intellectual property rights

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News